Navigation Links
Hologic And Gen-Probe Provide Update On Pending Transaction
Date:7/11/2012

is contingent on the satisfaction of certain conditions set forth in the previously disclosed Commitment Letter for the financing, including that there not having occurred, since December 31, 2011, an Acquired Business Material Adverse Effect (as defined in the Commitment Letter). The closing of each of these financing facilities is expected to take place concurrently with the completion of Hologic's acquisition of Gen-Probe.

Hologic's Preliminary Third Quarter Fiscal 2012 Financial Results:In connection with the commencement of syndication efforts relating to the financing, Hologic today provided preliminary fiscal third quarter 2012 financial results and its full fiscal 2012 revenue and non-GAAP adjusted earnings per share (EPS) outlook.

Based on preliminary financial data, Hologic expects the following for the third quarter of fiscal 2012 as compared to the corresponding period in the prior year: (i) revenues of approximately $470 million as compared to $451.1 million; (ii) non-GAAP adjusted net income in the range of $90 million to $93 million as compared to $85.7 million; (iii) non-GAAP adjusted EPS in the range of $0.34 to $0.35 as compared to $0.32; and (iv) non-GAAP adjusted EBITDA of over $160 million as compared to $154.6 million (non-GAAP adjusted EBITDA is defined as non-GAAP adjusted net income plus: interest expense, net; income taxes; and depreciation and amortization, included in its non-GAAP adjusted net income).

Hologic is also reaffirming the low-end of its full year 2012 revenue guidance of $1.9 billion and its non-GAAP adjusted EPS range of $1.36 to $1.38, as previously provided. This guidance includes Hologic's current operations and does not include the results of Gen-Probe.

Principal factors impacting the Company's third quarter revenue results include a significant acceleration in the shift of orders from 2D digital mammography systems to its new Dimensions 3D breast tomosynthesis systems, as well as customer or
'/>"/>

SOURCE Hologic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Hologic, Inc. Announces Note Offering
2. Hologic Breast Tomosynthesis (3D Mammography) System Places First in KLAS Annual Survey of Mammography Equipment Users
3. Hologic to Release Third Quarter Fiscal 2012 Operating Results on Monday, July 30, 2012
4. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
5. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
6. Gen-Probe Withdraws from Previously Announced Investor Presentations
7. BSGI Molecular Breast Imaging Provides Better Results than MRI for Cancer Patients with Dense Breasts
8. ERT Acquires invivodata to Establish the Industrys Most Experienced Provider of Clinical Outcome Assessment Solutions
9. TPI Provides Further Updates on its GMOL Flagship Product
10. PatientPay from Zepherella Now Offers Real-time Pricing, Automatic Payment Reconciliation for Healthcare Providers and Patients
11. Providers of Durable Medical Equipment Ensure Independence and Safety during Extreme Weather and Power Outages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... NEW YORK , May 22, 2015 /PRNewswire/ ... segment of the $13 billion global cardiac rhythm ... Kalorama Information.  Kalorama found that Medtronic, St. Jude ... Medical) command 80% of this market segment. The ... Management Device Markets , uses 2015 as a ...
(Date:5/22/2015)... , May 22, 2015 The ... in 2014 and is estimated to reach $90.7 million by ... Browse through the TOC of North America Dental ... with the help of various tables and figures. ... 10% customization on this report.   Dental ...
(Date:5/22/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage ... regeneration, today announced that J.J. Finkelstein , chief ... corporate overview at two upcoming investor conferences. ... th Annual Microcap Conference on Thursday May 28, ... at 11:00 am EDT.  A webcast will be available ...
Breaking Medicine Technology:Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3
... July 12, 2011 Magellan Biosciences, a global ... easier, more cost-effective, and less labor intensive, announced ... Systems-brand Sensititre AIM Automated Inoculation Delivery System for ... Sensititre AIM System quickly and accurately doses microtitre ...
... Particle Sciences Inc. (PSI), a ... provider of pre-clinical pharmacokinetic services, announced today that ... their clients with enhanced drug development services by ... development scheme.   According to Robert ...
Cached Medicine Technology:New FDA-Cleared Sensititre® AIM™ Automated Inoculation Delivery System Provides Faster, Accurate Dosing of MIC Plates for Microbiology Laboratories 2New FDA-Cleared Sensititre® AIM™ Automated Inoculation Delivery System Provides Faster, Accurate Dosing of MIC Plates for Microbiology Laboratories 3Particle Sciences and Absorption Systems Form Relationship to Offer their Clients Enhanced Services 2
(Date:5/22/2015)... 22, 2015 ZH Healthcare ... solutions, announced today that Bill Lane, joins ZH’s ... developer of BlueEHS,a first of its kind, Freemium ... customizable Electronic Health Records (EHR) with an integrated ... telemedicine-enabled comprehensive patient portal, and more. Combined with ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Gateway Building ... exterior renovations. The services the company specialize in include ... remodeling, basements, pool houses and much more. , ... by the owner of the company. It includes two ... The design was thought out to be used with ...
(Date:5/22/2015)... A Phase 3 French study, which ... Clinical Oncology (ASCO)’s annual meeting at the end ... patients who received bevacizumab in addition to the ... Genentech, Inc.) is an antibody that blocks angiogenesis ... used to treat many other cancers, including lung ...
(Date:5/22/2015)... 22, 2015 Ticket Down is a reputable ... Rangers NHL Eastern Conference Finals Tickets . All seating ... otherwise in the ticket listing. , For the first ... the top of the Eastern Conference. One of the original ... of ups and downs over the years, but the excitement ...
(Date:5/22/2015)... In April 2006, Veatch Consulting opened ... years they have concentrated their focus to working with ... Because of this growth and their goals to better ... Denver, Colorado, Cleveland, Ohio, Houston, Texas and now Dallas, ... dental offices, dental start ups, orthodontic practices, pediatric dental ...
Breaking Medicine News(10 mins):Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3
... (Nasdaq: DATA ), a technology and services company ... today reported its,operating results for the fourth quarter and ... ended December 31, 2007, revenue decreased,approximately 54% to $1,839,000 ... $(0.18) per share on both a basic and diluted ...
... 26 Bad reactions to a,prescribed medication send more ... Just 10 commonly used medications -- almost all,of them ... of these,reactions. The March 2008 issue of the Harvard ... potentially tricky medications., Warfarin: Check your bleeding time ...
... lead clinical efforts of Pennsylvania-based contracts, HARRISBURG, ... rapidly,expanding national medical management firm, named Stuart B. ... who replaces retiring medical,director, Frank Castrina, MD, will ... KePRO,s Harrisburg headquarters., "Dr. Chesky,s combined medical ...
... Unique, crystalline laxative designed to enhance patient acceptance and ... ... 26 Kristalose(R), a prescription,laxative product that treats acute and chronic ... a prescription,alternative to MiraLAX(R) and generic PEG 3350 products. Marketed in ...
... Plexus Systems, Inc.,provider of Plexus Online on-demand software ... Senior Account Manager of the,Western United States. He ... needs are met., (Logo: http://www.newscom.com/cgi-bin/prnh/20070627/CLW071LOGO ... record of selling and delivering large,Enterprise Resource Planning ...
... Physician Practices in Florida and Texas, ... Availity,L.L.C. and Prematics(TM) today announced an ... electronic prescribing service under,Availity,s private label, CarePrescribe(SM). ... physician support on behalf of Availity and,its ...
Cached Medicine News:Health News:DATATRAK International Reports Fourth Quarter and Full Year Results for 2007 2Health News:DATATRAK International Reports Fourth Quarter and Full Year Results for 2007 3Health News:DATATRAK International Reports Fourth Quarter and Full Year Results for 2007 4Health News:DATATRAK International Reports Fourth Quarter and Full Year Results for 2007 5Health News:DATATRAK International Reports Fourth Quarter and Full Year Results for 2007 6Health News:DATATRAK International Reports Fourth Quarter and Full Year Results for 2007 7Health News:DATATRAK International Reports Fourth Quarter and Full Year Results for 2007 8Health News:Tips for Troublesome Medications, From the Harvard Heart Letter 2Health News:KePRO Names Stuart B. Chesky, DO, JD, as Pennsylvania Medical Director 2Health News:KePRO Names Stuart B. Chesky, DO, JD, as Pennsylvania Medical Director 3Health News:Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products 2Health News:Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products 3Health News:Plexus Systems, Inc. Names Khanna to Senior Account Manager - Western Region 2Health News:Availity Engages Prematics to Deploy Electronic Prescribing 2Health News:Availity Engages Prematics to Deploy Electronic Prescribing 3
... Ultra High Throughput Screening (UHTS), Analyst ... performance. Allows for smooth transfer of ... by sharing all the detection modalities ... intensity, fluorescence polarization, time-resolved fluorescence, luminescence, ...
... POLARstar OPTIMA is a fully automated ... five different measurement principles:, , Fluorescence ... Time-Resolved Fluorescence , High-Performance Luminescence ... ,It is designed for ...
... assays, in 6 to 1536 well formats, ... is the instrument that can meet all ... the AlphaScreen assay platform. There are ... Reads AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) ...
VICTOR2 V measures prompt fluorescence, fluorescence polarization, luminescence, time-resolved fluorescence and absorbance. This model includes high density TRF (for 1536-well plates), temperature ...
Medicine Products: